Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer

Rationale: Siglec15 is an emerging target for normalization cancer immunotherapy. However, pan-cancer anti-Siglec15 treatment is not yet validated and the potential role of Siglec15 in bladder cancer (BLCA) remains elusive. Methods: We comprehensively evaluated the expression pattern and immunologic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Hu, Jiao, Yu, Anze, Othmane, Belaydi, Qiu, Dongxu, Li, Huihuang, Li, Chao, Liu, Peihua, Ren, Wenbiao, Chen, Minfeng, Gong, Guanghui, Guo, Xi, Zhang, Huihui, Chen, Jinbo, Zu, Xiongbing
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2021
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7847675/
https://ncbi.nlm.nih.gov/pubmed/33537076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.53649
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados